The antileishmanial activity of novel oxygenated chalcones and their mechanism of action
Authors:
- Ming ChenMCMing Chen
- Jens BlomJBJens Blom
- Thor G. TheanderTTThor G. Theander
- Søren Brøgger ChristensenSCSøren Brøgger Christensen
- Arsalan KharazmiAKArsalan Kharazmi
Open Access
- 1 June 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 43 (6) , 793-803
Abstract
Our previous studies have shown that licochalcone A, an oxygenated chalcone, has antileishmanial and antimalarial activities, and alters the ultrastructure and function of the mitochondria of Leishmania spp. parasites. The present study was designed to investigate the antileishmanial activity and the mechanism of action of a group of new oxygenated chalcones. The tested oxygenated chalcones inhibited the in-vitro growth of Leishmania major promastigotes and Leishmania donovani amastigotes. Treatment of hamsters infected with L.donovani with intraperitoneal administration of two oxygenated chalcones resulted in a significant reduction of parasite load in the liver and the spleen compared with untreated control animals. The oxygenated chalcones also inhibited the respiration of the parasite and the activity of mitochondrial dehydrogenases. Electron microscopic studies illustrated that they altered the ultrastructure of the mitochondria of L. major promastigote. The data clearly indicate that this group of oxygenated chalcones has a strong antileishmanial activity and might be developed into a new antileishmanial drug. The antileishmanial activity of oxygenated chalcones might be the result of interference with function of the parasite mitochondria.Keywords
This publication has 11 references indexed in Scilit:
- The Novel Oxygenated Chalcone, 2,4‐Dimethoxy‐4'‐Butoxychalcone, Exhibits Potent Activity against Human Malaria ParasitePlasmodium falciparumIn Vitro and Rodent ParasitesPlasmodium bergheiandPlasmodium yoeliiIn VivoThe Journal of Infectious Diseases, 1997
- AIDS and Leishmania infantumClinics in Dermatology, 1996
- The antileishmanial agent licochalcone A interferes with the function of parasite mitochondriaAntimicrobial Agents and Chemotherapy, 1995
- Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovaniAntimicrobial Agents and Chemotherapy, 1994
- The use of a water-soluble formazan complex to quantitate the cell number and mitochondrial function ofLeishmania major promastigotesParasitology Research, 1994
- Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of LeishmaniaAntimicrobial Agents and Chemotherapy, 1993
- Practical progress and new drugs for changing patterns of leishmaniasisParasitology Today, 1993
- Leishmania donovani: Long-term culture of axenic amastigotes at 37 °CExperimental Parasitology, 1991
- Effects of β-lapachone, a peroxide-generating quinone, on macromolecule synthesis and degradation in Trypanosoma cruziArchives of Biochemistry and Biophysics, 1985
- An Eight‐day Method for Screening Compounds against Leishmania donovani in the Golden Hamster*The Journal of Protozoology, 1958